ATI RN
Cardiovascular System Exam Questions Pdf
1. The healthcare provider is administering IV nitroglycerin to a patient for chest pain. What is the most critical parameter to monitor?
- A. Heart rate
- B. Blood pressure
- C. Oxygen saturation
- D. Respiratory rate
Correct answer: B
Rationale: The correct answer is 'Blood pressure.' Nitroglycerin is a vasodilator that can cause a rapid drop in blood pressure, leading to hypotension. Monitoring the blood pressure is crucial to prevent potential complications such as hypotension-induced dizziness, syncope, or organ hypoperfusion. While heart rate, oxygen saturation, and respiratory rate are important parameters to monitor in a clinical setting, the immediate concern with IV nitroglycerin administration is the risk of hypotension, making blood pressure the most critical parameter to assess.
2. This is a type of therapy that involves removing fluid from the lungs, typically through the use of diuretics.
- A. Diuretic therapy
- B. Oxygen therapy
- C. Inhaler therapy
- D. Antihistamine therapy
Correct answer: A
Rationale: The correct answer is A: Diuretic therapy. Diuretic therapy involves the use of medications that help remove excess fluid from the body, often used to treat conditions like pulmonary edema. Choice B, Oxygen therapy, is used to provide oxygen to patients with breathing difficulties but does not involve removing fluid from the lungs. Choice C, Inhaler therapy, is used to deliver medication directly to the lungs to help with respiratory conditions but does not focus on removing fluid. Choice D, Antihistamine therapy, is used to treat allergies by blocking histamine but is not related to removing fluid from the lungs.
3. What is a blood clot that forms in a vein, often in the legs, and can cause serious complications if it travels to the lungs?
- A. Deep vein thrombosis (DVT)
- B. Pulmonary embolism
- C. Varicose veins
- D. Atherosclerosis
Correct answer: A
Rationale: The correct answer is Deep vein thrombosis (DVT). DVT is a blood clot that forms in a deep vein, typically in the legs, and can lead to serious complications if it breaks loose and travels to the lungs, causing a pulmonary embolism. Varicose veins (choice C) are enlarged, twisted veins usually found in the legs but are not related to blood clots. Atherosclerosis (choice D) is a condition where arteries become narrowed and hardened due to a buildup of plaque, not directly related to blood clots.
4. Which test measures how much and how quickly you can move air out of your lungs?
- A. Spirometry
- B. Peak flow meter
- C. Lung volume test
- D. Arterial blood gas
Correct answer: A
Rationale: The correct answer is A, Spirometry. Spirometry is a common pulmonary function test that measures lung function by assessing the amount (volume) and speed (flow) of air that can be inhaled and exhaled. This test helps in diagnosing conditions like asthma, chronic obstructive pulmonary disease (COPD), and other lung diseases. Peak flow meter (choice B) measures the maximum speed at which a person can exhale air, mainly used in asthma management. Lung volume test (choice C) evaluates the total amount of air the lungs can hold. Arterial blood gas (choice D) measures the levels of oxygen and carbon dioxide in the blood, providing information on how well the lungs are functioning in gas exchange, but it does not specifically measure the amount and speed of air movement in and out of the lungs like spirometry does.
5. The client is on spironolactone (Aldactone) and has a potassium level of 5.9 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer potassium supplements.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.9 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, the priority action is to hold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further guidance. Choice B is incorrect because administering potassium supplements would worsen hyperkalemia. Choice C is incorrect because continuing spironolactone could lead to a further increase in potassium levels. Choice D is incorrect because increasing the dose of spironolactone would exacerbate the hyperkalemia.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access